Alzheimer’s & Dementia News Roundup (May 2026)
A monthly recap of the latest news about Alzheimer’s and dementia FDA approves a second drug for agitation associated with Alzheimer’s disease – and it’s not an antipsychotic medication On April 30, the FDA granted approval for a combination medication of dextromethorphan and bupropion for the treatment of agitation in Alzheimer’s disease. Read more.











